United Therapeutics Corporation (UTHR)

NMS – Цена в реальном времени. Валюта: USD

519.81

+4.31 (0.84%)

Рынок открыт: Aug 12, 2026, 11:36 AM EDT

514.67

-0.83 (-0.16%)

Предыдущая сессия: Aug 11, 2026, 7:34 PM EDT

06.08.2026

United Therapeutics Q2 Earnings Beat Estimates, Revenues Miss Mark

UTHR tops Q2 EPS estimates, misses revenues, while advancing Tyvaso and ralinepag programs that reshape future growth.

05.08.2026

United Therapeutics Q2 Earnings Call Highlights

United Therapeutics NASDAQ: UTHR reported second-quarter 2026 revenue of approximately $783 million, essentially flat from the first quarter, as competitive pressure affected sales of its nebulized TYVASO therapy. Company executives said they expect stronger performance in the second half of the year but did not reaffirm or update previous 2026 revenue-growth expectations.

05.08.2026

United Therapeutics Corporation (UTHR) Q2 2026 Earnings Call Transcript

05.08.2026

United Therapeutics (UTHR) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for United Therapeutics (UTHR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

05.08.2026

United Therapeutics (UTHR) Q2 Earnings Surpass Estimates

United Therapeutics (UTHR) came out with quarterly earnings of $7.27 per share, beating the Zacks Consensus Estimate of $6.82 per share. This compares to earnings of $6.41 per share a year ago.

05.08.2026

United Therapeutics Corporation Reports Second Quarter 2026 Financial Results

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended June 30, 2026. Total revenues in the second quarter of 2026 decreased by two percent year-over-year to $783.3 million, compared to $798.6 million in the second quarter of 2025. “We just submitted what we believe are two of the most important NDAs in rare pulmonary disease history: ralinepag t.

03.08.2026

UTHR or SDZNY: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Drugs stocks are likely familiar with United Therapeutics (UTHR) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two companies is the best option for those looking for undervalued stocks?

Видео

No Data

There is no data to display

Пресс-релизы

05.08.2026

United Therapeutics Corporation (UTHR)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

United Therapeutics Corporation (UTHR)

United Therapeutics Q2 Earnings Beat Estimates, Revenues Miss Mark

United Therapeutics Q2 Earnings Call Highlights

United Therapeutics Corporation (UTHR) Q2 2026 Earnings Call Transcript

United Therapeutics (UTHR) Reports Q2 Earnings: What Key Metrics Have to Say

United Therapeutics (UTHR) Q2 Earnings Surpass Estimates

United Therapeutics Corporation Reports Second Quarter 2026 Financial Results

UTHR or SDZNY: Which Is the Better Value Stock Right Now?

Видео

No Data

Пресс-релизы

United Therapeutics Corporation Reports Second Quarter 2026 Financial Results

United Therapeutics Q2 Earnings Beat Estimates, Revenues Miss Mark

United Therapeutics Q2 Earnings Call Highlights

United Therapeutics Corporation (UTHR) Q2 2026 Earnings Call Transcript

United Therapeutics (UTHR) Reports Q2 Earnings: What Key Metrics Have to Say

United Therapeutics (UTHR) Q2 Earnings Surpass Estimates

United Therapeutics Corporation Reports Second Quarter 2026 Financial Results

UTHR or SDZNY: Which Is the Better Value Stock Right Now?

Видео

No Data

Пресс-релизы

United Therapeutics Corporation Reports Second Quarter 2026 Financial Results

Search stocks

United Therapeutics Corporation (UTHR)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

United Therapeutics Corporation (UTHR)

United Therapeutics Q2 Earnings Beat Estimates, Revenues Miss Mark

United Therapeutics Q2 Earnings Call Highlights

United Therapeutics Corporation (UTHR) Q2 2026 Earnings Call Transcript

United Therapeutics (UTHR) Reports Q2 Earnings: What Key Metrics Have to Say

United Therapeutics (UTHR) Q2 Earnings Surpass Estimates

United Therapeutics Corporation Reports Second Quarter 2026 Financial Results

UTHR or SDZNY: Which Is the Better Value Stock Right Now?

Видео

No Data

Пресс-релизы

United Therapeutics Corporation Reports Second Quarter 2026 Financial Results

United Therapeutics Q2 Earnings Beat Estimates, Revenues Miss Mark

United Therapeutics Q2 Earnings Call Highlights

United Therapeutics Corporation (UTHR) Q2 2026 Earnings Call Transcript

United Therapeutics (UTHR) Reports Q2 Earnings: What Key Metrics Have to Say

United Therapeutics (UTHR) Q2 Earnings Surpass Estimates

United Therapeutics Corporation Reports Second Quarter 2026 Financial Results

UTHR or SDZNY: Which Is the Better Value Stock Right Now?

Видео

No Data

Пресс-релизы

United Therapeutics Corporation Reports Second Quarter 2026 Financial Results